Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa

被引:4
作者
Centner, C. M. [1 ,2 ]
Munir, R. [3 ]
Tagliani, E. [4 ]
Riess, F. [5 ]
Brown, P. [1 ]
Hayes, C. [6 ]
Dolby, T. [7 ]
Zemanay, W.
Cirillo, D. M. [4 ]
David, A. [3 ]
Schumacher, S. G.
Denkinger, C. M. [8 ,9 ,10 ]
Ruhwald, M. [8 ]
Leukes, V. N. [8 ]
Nicol, M. P. [11 ]
van der Walt, I [6 ]
Kisten, G. [7 ]
Gumede, M. [7 ]
Mace, A. [8 ]
Brink, A. [1 ,2 ,12 ,13 ]
Stevens, W. [3 ,14 ]
Scott, L. [3 ,14 ]
Penn-Nicholson, A. [8 ]
Cox, H. [1 ,12 ,13 ]
机构
[1] Univ Cape Town, Dept Pathol, Div Med Microbiol, Cape Town, South Africa
[2] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, WITS Diagnost Innovat Hub, Sch Pathol, Johannesburg, South Africa
[4] IRCCS Osped San Raffaele, Emerging Bacterial Pathogens Unit, Milan, Italy
[5] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Div Infect Dis & Trop Med, Munich, Germany
[6] Natl Hlth Lab Serv, Gqeberha, South Africa
[7] Natl Hlth Lab Serv, Cape Town, South Africa
[8] FIND, TB Programme, Geneva, Switzerland
[9] Heidelberg Univ Hosp, Ctr Infect Dis, Div Infect Dis & Trop Med, Heidelberg, Germany
[10] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany
[11] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Biomed Sci, Perth, WA, Australia
[12] Univ Cape Town, Welcome Ctr Infect Dis Res Afr, Sch Biomed Sci, Cape Town, South Africa
[13] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa
[14] Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa
关键词
diagnostic accuracy; drug resistance; feasibility; tuberculosis; Xpert MTB/XDR; 2ND-LINE DRUGS; TUBERCULOSIS; CARE;
D O I
10.1093/ofid/ofae437
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background The World Health Organization-approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and injectable drugs directly in specimens. This pragmatic, laboratory-based study assessed the diagnostic accuracy and feasibility of a reflex testing approach, where Xpert MTB/XDR was performed on residual specimens previously processed for Xpert MTB/RIF Ultra.Methods Routine respiratory specimens, processed for Xpert MTB/RIF Ultra, were stored in sample reagent buffer at 2 degrees C-8 degrees C. If rifampicin resistant, the residual specimen was assessed for adequate volume (>= 2 mL) and tested with Xpert MTB/XDR, with storage time recorded. A second specimen was used for routine and reference standard testing (culture and sequencing).Results Specimens (99% sputum) from 763 participants submitted to 2 large routine laboratories were included. Xpert MTB/XDR yielded valid resistance detection results in 639 (84%), compared with 507 (66%) for routine testing (difference [95% CI], 18% [13%-22%]). The median turnaround time for results was 23 hours for Xpert MTB/XDR and 15 days for routine testing. While 748 specimens (98%) were >= 2 mL, only 102 (13%) were stored for <= 4 hours. By the reference standard, 284 of 394 (72%) were isoniazid resistant, and 57 of 380 (15%) were fluroquinolone resistant. The sensitivities of Xpert MTB/XDR were 94% (95% CI, 91%-97%) for isoniazid and 91% (81%-97%) for fluoroquinolone resistance detection. The specificities were 98% (94%-100%) and 100% (98%-100%), respectively.Conclusions Xpert MTB/XDR performed favorably compared with the reference, and the reflex testing approach increased results availability over routine testing, while dramatically decreasing turnaround time from weeks to hours. Laboratory workflow precluded testing within the manufacturer-recommended 4-hour storage time, but longer storage did not appear detrimental. The Xpert MTB/XDR assay performed favorably for the detection of isoniazid, fluoroquinolones, and injectable tuberculosis drug resistance in a reflex testing algorithm that dramatically reduced turnaround time in 2 high-throughput clinical laboratories. Graphical Abstract https://tidbitapp.io/tidbits/reflex-xpert-mtb-xdr-testing-of-residual-rifampicin-resistant-specimens-a-clinical-laboratory-based-diagnostic-accuracy-and-feasibility-study-in-south-africa
引用
收藏
页数:10
相关论文
共 24 条
[1]  
[Anonymous], 2016, USE MOL LINE PROBE A
[2]   Discordance across Several Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Single Laboratory [J].
Banu, Sayera ;
Rahman, S. M. Mazidur ;
Khan, M. Siddiqur Rahman ;
Ferdous, Sara Sabrina ;
Ahmed, Shahriar ;
Gratz, Jean ;
Stroup, Suzanne ;
Pholwat, Suporn ;
Heysell, Scott K. ;
Houpt, Eric R. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (01) :156-163
[3]   Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis [J].
Bastos, Mayara L. ;
Hussain, Hamidah ;
Weyer, Karin ;
Garcia-Garcia, Lourdes ;
Leimane, Vaira ;
Leung, Chi Chiu ;
Narita, Masahiro ;
Pena, Jose M. ;
Ponce-de-Leon, Alfredo ;
Seung, Kwonjune J. ;
Shean, Karen ;
Sifuentes-Osornio, Jose ;
Van der Walt, Martie ;
Van der Werf, Tjip S. ;
Yew, Wing Wai ;
Menzies, Dick .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (10) :1364-1374
[4]   Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade [J].
Cazabon, Danielle ;
Alsdurf, Hannah ;
Satyanarayana, Srinath ;
Nathavitharana, Ruvandhi ;
Subbaraman, Ramnath ;
Daftary, Amrita ;
Pai, Madhukar .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 56 :111-116
[5]   Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use [J].
Chakravorty, Soumitesh ;
Roh, Sandy S. ;
Glass, Jennifer ;
Smith, Laura E. ;
Simmons, Ann Marie ;
Lund, Kevin ;
Lokhov, Sergey ;
Liu, Xin ;
Xu, Peng ;
Zhang, Guolong ;
Via, Laura E. ;
Shen, Qingyu ;
Ruan, Xianglin ;
Yuan, Xing ;
Zhu, Hong Zhu ;
Viazovkina, Ekaterina ;
Shenai, Shubhada ;
Rowneki, Mazhgan ;
Lee, Jong Seok ;
Barry, Clifton E., III ;
Gao, Qian ;
Persing, David ;
Kwiatkawoski, Robert ;
Jones, Martin ;
Gall, Alexander ;
Alland, David .
JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (01) :183-198
[6]   Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey [J].
Ismail, Nazir Ahmed ;
Mvusi, Lindiwe ;
Nanoo, Ananta ;
Dreyer, Andries ;
Omar, Shaheed V. ;
Babatunde, Sanni ;
Molebatsi, Thabo ;
van der Walt, Martie ;
Adelekan, Adeboye ;
Deyde, Varough ;
Ihekweazu, Chikwe ;
Madhi, Shabir A. .
LANCET INFECTIOUS DISEASES, 2018, 18 (07) :779-787
[7]   Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study [J].
Jacobson, Karen R. ;
Barnard, Marinus ;
Kleinman, Mary B. ;
Streicher, Elizabeth M. ;
Ragan, Elizabeth J. ;
White, Laura F. ;
Shapira, Ofer ;
Dolby, Tania ;
Simpson, John ;
Scott, Lesley ;
Stevens, Wendy ;
van Helden, Paul D. ;
Van Rie, Annelies ;
Warren, Robin M. .
CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) :1502-1508
[8]   MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates [J].
Kohl, Thomas Andreas ;
Utpatel, Christian ;
Schleusener, Viola ;
De Filippo, Maria Rosaria ;
Beckert, Patrick ;
Cirillo, Daniela Maria ;
Niemann, Stefan .
PEERJ, 2018, 6
[9]   Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study [J].
Kraef, Christian ;
Bentzon, Adrian ;
Panteleev, Alexander ;
Skrahina, Alena ;
Bolokadze, Natalie ;
Tetradov, Simona ;
Podlasin, Regina ;
Karpov, Igor ;
Borodulina, Elena ;
Denisova, Elena ;
Azina, Inga ;
Lundgren, Jens ;
Johansen, Isik Somuncu ;
Mocroft, Amanda ;
Podlekareva, Daria ;
Kirk, Ole .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[10]   Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda [J].
Ngabonziza, J-C S. ;
Habimana, Y. M. ;
Decroo, T. ;
Migambi, P. ;
Dushime, A. ;
Mazarati, J. B. ;
Rigouts, L. ;
Affolabi, D. ;
Ivan, E. ;
Meehan, C. J. ;
Van Deun, A. ;
Fissette, K. ;
Habiyambere, I ;
Nyaruhirira, A. U. ;
Turate, I ;
Semahore, J. M. ;
Ndjeka, N. ;
Muvunyi, C. M. ;
Condo, J. U. ;
Gasana, M. ;
Hasker, E. ;
Torrea, G. ;
de Jong, B. C. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (03) :329-+